EmeTerm(TM) Offers Solution to VR Motion Sickness

Tuesday, June 6, 2017 General News
Email Print This Page Comment
Font : A-A+

VANCOUVER, British Columbia, June 6, 2017 /PRNewswire/ -- Researchers have recently

confirmed that virtual reality headsets tend to cause a form of motion sickness known as VR sickness, which induces nausea and vomiting. While developmental teams have tried to combat this issue, its prevalence remains common. Many in the industry fear
that this will be a major obstacle for virtual reality to be adopted to the general public.

WAT Med attended LifeSciences BC's Health Networking event on May 17th and had the pleasure to meet Dr. Robert DiRaddo, the Section Head of Simulation and Digital Health at the National Research Council of Canada (NRC). Dr. DiRaddo's team develops mathematically-based interactive virtual reality and artificial intelligence technology for a wide range of uses, including neurosurgical training for surgeons, flying training for pilots, and anxiety control for airplane passengers.

Dr. DiRaddo expressed his interest in WAT Med's leading product, EmeTerm™, as a potential solution to motion sickness-induced vomiting. EmeTerm™'s innovative design and usability has received positive feedback from many other medical professionals at the event. EmeTerm™ is winner of iF Design Award 2017 with high level water-resist, magnetic recharging system, ergonomics design and medical level materials. 

WAT Med remains in contact with NRC and are looking forward to offer solution for VR sickness and for other collaboration opportunities.

Company: WAT Medical Enterprise Ltd.Website: www.watmedical.comEmail: info@watmedical.com                                     

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/emetermtm-offers-solution-to-vr-motion-sickness-300469380.html

SOURCE WAT Medical Enterprise Ltd.



Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Advertisement
Advertisement

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook